SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-03-003582
Filing Date
2003-03-31
Accepted
2003-03-31 10:02:16
Documents
7
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 REGENERON PHARMACEUTICALS INC. y84123e10vk.htm 10-K 881743
3 EX-10.6.1 AMENDMENT #1 TO LONG TERM INCENTIVE PLAN y84123exv10w6w1.htm EX-10.6.1 7014
4 EX-10.6.2 AMENDMENT #2 TO LONG TERM INCENTIVE PLAN y84123exv10w6w2.htm EX-10.6.2 3712
5 EX-10.18 EMPLOYMENT AGREEMENT y84123exv10w17.htm EX-10.17 92946
6 EX-23.1 CONSENT OF PRICEWATERHOUSECOOPERS LLP y84123exv23w1.htm EX-23.1 1364
7 EX-23.2 CONSENT OF ERNST & YOUNG LLP y84123exv23w2.htm EX-23.2 1998
8 EX-99.1: CERTIFICATIONS OF CEO AND CFO y84123exv99w1.htm EX-99.1 3990
  Complete submission text file 0000950123-03-003582.txt   995065
Mailing Address
Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000
REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19034 | Film No.: 03627526
SIC: 2834 Pharmaceutical Preparations